New lupus drug trial seeks to tame immune system
NCT ID NCT07266090
Summary
This study is testing the safety and how the body processes a new drug called cenerimod in Chinese adults with moderate-to-severe lupus. Participants will take a daily pill for up to a year while continuing their current lupus medications. The main goal is to see if the drug is safe and well-tolerated, and to measure its levels in the blood and its effect on certain immune cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE - SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, 471003, China
-
First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330200, China
-
First People's Hospital of Jiujiang
Jiujiang, Jiangxi, 332000, China
-
Peking Union Medical College Hospital
Beijing, 100010, China
-
The First Affiliated Hospital Of Jinan University
Guangzhou, Guangdong, 510630, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
-
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
Conditions
Explore the condition pages connected to this study.